47 results on '"Jan Albert"'
Search Results
2. Protection against high-fat diet induced obesity, dyslipidaemia, and fatty liver in a preclinical setting
3. Hepatic Retromer is critical for systemic cholesterol homeostasis via shaping the endo-lysosomal organization
4. SMLR1 is a novel player in chylomicron metabolism
5. GPR146 and HDL metabolism
6. Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model
7. A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity
8. Large HDL particles negatively associate with leukocyte counts independent of cholesterol efflux capacity: A cross sectional study in the population-based LifeLines DEEP cohort
9. Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes
10. Adeno-associated virus LPL S447X gene therapy in LDL receptor knockout mice
11. A cargo-specific role for hepatocyte retriever in lipoprotein receptor recycling
12. A novel gene affecting VLDL assembly/secretion
13. Silencing of FoXO1 gene in the livers of ApoE*3L.CETP mice with mets affects the expression of genes related to glucose metabolism and improves glucose tolerance
14. Rare GPR146 variants and their impact in the regulation of plasma lipid levels
15. GENDER-SPECIFIC DIFFERENCES AT BOTH EXTREME ENDS OF THE LDL CHOLESTEROL DISTRIBUTION CURVE
16. The coatomer (COP I) complex limits the cell-surface abundance of the ldl receptor and cellular LDL uptake
17. The U2-spliceosome and its interactors regulate the levels and activity of the LDL receptor in humans
18. FXR activation normalizes dyslipidemia and alleviates obesity in western-type diet–fed APOE*3-Leiden.CETP transgenic mice
19. What Is The Origin Of Severe Hypercholesterolemia In A Large Cohort Of Emiratis With A High Prevalance Of Type 2 Diabetes
20. Corrigendum to “Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.” [Atherosclerosis 274 (July 2018) 120–127]
21. Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle
22. The Parkinson’s Disease Gene Vps35 Regulates Plasma Ldl Cholesterol Levels In A Ccc/Wash-Dependent Manner
23. A Common Variant In Ccdc93 Decreases Ldl-C And Protects Against Myocardial Infarction By Regulating Endosomal Trafficking Of Ldl-Receptor
24. Genetics, lifestyle and LDL cholesterol in young and apparently healthy women
25. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol
26. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants
27. Revealing the role of the endosmal sorting machinery in cholesterol homeostasis
28. Multilocus gene score or a metabolic risk score for severe hypertriglyceridemia and CVD risk prediction
29. Adeno-associated virus LPL(S447X) gene therapy in LDL receptor knockout mice
30. Revealing the role of the endosmal sorting machinery in cholesterol homeostasis
31. Multilocus gene score or a metabolic risk score for severe hypertriglyceridemia and CVD risk prediction
32. Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia
33. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?
34. Regulation of HDL-c levels via ABCA1 : A role for Lrp1
35. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism
36. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase
37. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?
38. The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia
39. Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: Studies in mice and FH children
40. Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness
41. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism
42. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism
43. Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia
44. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants
45. Adeno-associated virus LPLS447X gene therapy in LDL receptor knockout mice
46. The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia
47. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.